FormanBiotech Holding ApS: Financial statements 2023
CVR: 42542849
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
FormanBiotech Holding ApS (CVR 42542849) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -4,621 and a net result of DKK 9,729. Equity in the 2023 report amounted to DKK 6,739,993. The solvency ratio was 100%.
- Gross Profit
- DKK -4,621
- Profit/Loss
- DKK 9,729
- Equity
- DKK 6,739,993
- Total Assets
- DKK 6,739,993
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
FormanBiotech Holding ApS has published its interim report for the period July 12, 2021 to December 31, 2022.
About FormanBiotech Holding ApS
FormanBiotech Holding ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Victor Forman. The company is owned by Victor Forman. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,876 and a net result of DKK 85,326 compared with DKK -2,512,116 the year before. Equity in the 2025 report amounted to DKK 4,313,203.